Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
3(33%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
1
11%
Ph not_applicable
2
22%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Recruiting3
Completed2
Enrolling by invitation1
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

enrolling_by_invitation111%
not_yet_recruiting111%
recruiting333%
terminated111%
unknown111%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
9